Clinical Trials on Relapsing Remitting Multiple Sclerosis in United Kingdom
Total 1433 results
-
Jazz PharmaceuticalsCompletedMultiple Sclerosis | Neuropathic PainUnited Kingdom
-
Queen Margaret UniversityNHS LothianCompletedMultiple SclerosisUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustRecruitingPathologic Processes | Multiple Sclerosis | Sclerosis | Demyelinating Autoimmune Diseases, CNS | Autoimmune Diseases of the Nervous System | Autoimmune DiseasesUnited Kingdom
-
University Hospitals of North Midlands NHS TrustActive, not recruiting
-
VA Office of Research and DevelopmentCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedPrimary Progressive Multiple SclerosisUnited States
-
National Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
BayerCompletedMultiple SclerosisGermany, Austria, United Kingdom, Israel, Belgium, Finland
-
Atara BiotherapeuticsTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States, Australia, Canada
-
Stanford UniversityKyverna TherapeuticsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Emmanuelle Waubant, MD PhDUnited States Department of DefenseRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Jazz PharmaceuticalsCompletedPain | Multiple SclerosisUnited Kingdom
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedPrimary Progressive Multiple SclerosisUnited States, Canada, Germany, Italy, Netherlands, Poland, Russian Federation, Spain, Ukraine, United Kingdom
-
MediciNovaNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaboratorsCompletedSafety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Kessler FoundationInternational Progressive MS AllianceCompletedMemory Impairment | Cognition - Other | Multiple Sclerosis, ProgressiveUnited States
-
MorphoSys AGCompletedMultiple SclerosisGermany, Poland, United Kingdom
-
University of Texas Southwestern Medical CenterNational Multiple Sclerosis Society; International Progressive Multiple Sclerosis...RecruitingProgressive Multiple SclerosisUnited States
-
SanofiCompletedMultiple SclerosisUnited Kingdom
-
NYU Langone HealthCompleted
-
University of California, San FranciscoCompleted
-
Queen Mary University of LondonCompleted
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited Kingdom
-
University of UtahCompletedMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Secondary Progressive Multiple SclerosisUnited States
-
John F. Foley, MDGenzyme, a Sanofi CompanyCompletedMultiple Sclerosis | Clinically Isolated Syndrome | Secondary Progressive Multiple SclerosisUnited States
-
University of NottinghamRecruitingFeasibility of Neuromodulation With Connectivity-Guided iTBS for Cognitive Impairment in MS (TMS4MS)Multiple Sclerosis | Cognitive ImpairmentUnited Kingdom
-
Joanne Kurtzberg, MDRecruitingPrimary Progressive Multiple SclerosisUnited States
-
Terry L. WahlsCompleted
-
University of StirlingWithdrawnMultiple Sclerosis | Chronic Cerebrospinal Venous InsufficiencyUnited Kingdom
-
National Institute of Neurological Disorders and...Terminated
-
Jazz PharmaceuticalsCompletedMultiple Sclerosis | SpasticityUnited Kingdom
-
University of IowaDJO Incorporated; Direct MS Canada; Pinnaclife Inc.; TZ Press, LLCCompletedMultiple SclerosisUnited States
-
Queen Margaret UniversityRecruitingMultiple SclerosisUnited Kingdom
-
University of SheffieldSheffield Teaching Hospitals NHS Foundation Trust; Walton Centre NHS Foundation...CompletedDepression | Multiple SclerosisUnited Kingdom
-
MedDay Pharmaceuticals SATerminatedMultiple SclerosisUnited States, Spain, Canada, Australia, United Kingdom, Belgium, Turkey, Czechia, Poland, Italy, Hungary, Germany, Sweden
-
University of EdinburghCompleted
-
Wellspect HealthCareTerminatedMultiple Sclerosis | Bladder DysfunctionBelgium, Netherlands, Germany, United Kingdom
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
University of OxfordMultiple Sclerosis Society of Great Britain and Northern IrelandCompletedMultiple Sclerosis | Optic NeuritisUnited Kingdom
-
Queen Margaret UniversityNHS Lothian; Multiple Sclerosis Society UKCompletedMultiple Sclerosis | Foot DropUnited Kingdom
-
Institut fur Klinische Forschung, GermanyWeleda AGTerminated
-
Duke UniversityCompletedPrimary Progressive Multiple SclerosisUnited States
-
SanofiCompletedMultiple SclerosisUnited States, Canada, Germany, Italy, Spain, United Kingdom, Austria
-
University College, LondonUCLHUnknownMultiple Sclerosis | Recurrent Urinary Tract InfectionsUnited Kingdom
-
SanofiCompletedMultiple SclerosisUnited States, Canada, Germany, United Kingdom, Austria, Italy
-
Johns Hopkins UniversityHugo W. Moser Research Institute at Kennedy Krieger, Inc.CompletedSecondary Progressive Multiple SclerosisUnited States
-
Jazz PharmaceuticalsCompletedMultiple Sclerosis | SpasticityUnited Kingdom
-
VA Office of Research and DevelopmentActive, not recruitingMultiple SclerosisUnited States, Canada
-
Hoffmann-La RocheActive, not recruitingProgressive Multiple Sclerosis (PMS)United States, Canada, Brazil, France, Netherlands, Ireland, Germany, Italy, Poland, Russian Federation, Spain, Colombia, Morocco, Hungary, Denmark, Lebanon, Mexico, Costa Rica, Bosnia and Herzegovina, Czechia, Egypt, Guatemala, Panama and more
-
University of UtahMallinckrodtTerminatedOpen-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis (MSECP)Secondary Progressive Multiple SclerosisUnited States